Follow-up of avidity and titre of anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis

被引:20
作者
Gao, Ying
Chen, Min
Ye, Hua
Guo, Xiao-hui
Zhao, Ming-hui [1 ]
Wang, Hai-yan
机构
[1] Peking Univ, Hosp 1, Dept Nephrol, Beijing 100034, Peoples R China
[2] Peking Univ, Hosp 1, Dept Endocrinol, Beijing 100034, Peoples R China
关键词
D O I
10.1111/j.1365-2265.2007.02770.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Propylthiouracil (PTU) has been known to induce myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) positive vasculitis. Our previous study indicated that the increase of avidity of MPO-ANCA might be associated with the occurrence of clinical vasculitis in patients with PTU-induced ANCA. The current study aimed to follow-up the avidity and titre of anti-MPO antibodies in sequential sera from patients with PTU-induced ANCA-associated systemic vasculitis (AASV). Methods Six patients with PTU-induced vasculitis were enrolled in the current study. Serial sera in both active phase and in remission were collected. MPO-ANCA avidity was assessed by antigen-inhibition enzyme-linked immunosorbent assays (ELISAs), and avidity constant (aK) was determined as the reciprocal value of the MPO molar concentration in the liquid phase resulting in 50% inhibition of anti-MPO antibody binding to MPO in solid phase ELISA. Titres of MPO-ANCA were determined by using serial serum dilutions in MPO-ELISA. Results After cessation of PTU and initiation of immunosuppressive therapy, the avidity and titre of MPO-ANCA decreased significantly during follow-up in sera from all the patients, and the avidity decreased much more quickly than the titres. Conclusion Our study indicates that avidity of anti-MPO antibodies might be more closely associated with clinical vasculitis than titre.
引用
收藏
页码:543 / 547
页数:5
相关论文
共 23 条
[1]  
CAMBRIDGE G, 1994, BRIT J RHEUMATOL, V33, P109
[2]   VASCULITIS AND ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES ASSOCIATED WITH PROPYLTHIOURACIL THERAPY [J].
DOLMAN, KM ;
GANS, ROB ;
VERVAAT, TJ ;
ZEVENBERGEN, G ;
MAINGAY, D ;
NIKKELS, RE ;
DONKER, AJM ;
BORNE, AEGKV ;
GOLDSCHMEDING, R .
LANCET, 1993, 342 (8872) :651-652
[3]  
Fujieda M, 2002, J AM SOC NEPHROL, V13, P437, DOI 10.1681/ASN.V132437
[4]   Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis [J].
Gao, Y ;
Ye, H ;
Yu, F ;
Guo, XH ;
Zhao, MH .
CLINICAL IMMUNOLOGY, 2005, 117 (01) :87-93
[5]   The prevalence and target antigens of antithyroid drugs induced antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with hyperthyroidism [J].
Gao, Y ;
Zhao, MH ;
Guo, XH ;
Xin, G ;
Gao, Y ;
Wang, HY .
ENDOCRINE RESEARCH, 2004, 30 (02) :205-213
[6]   The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil [J].
Gao, Ying ;
Chen, Min ;
Ye, Hua ;
Guo, Xiao-Hui ;
Zhao, Ming-hui ;
Wang, Hai-yan .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2007, 7 (01) :55-60
[7]   Anti-thyroid drugs and antineutrophil cytoplasmic antibody positive vasculitis. A case report and review of the literature [J].
Gunton, JE ;
Stiel, J ;
Caterson, RJ ;
McElduff, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (01) :13-16
[8]   Serial ANCA titers: Useful tool for prevention of relapses in ANCA-associated vasculitis [J].
Han, WK ;
Choi, HK ;
Roth, RM ;
Mccluskey, RT ;
Niles, JL .
KIDNEY INTERNATIONAL, 2003, 63 (03) :1079-1085
[9]   Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease [J].
Harper, L ;
Chin, L ;
Daykin, J ;
Allahabadia, A ;
Heward, J ;
Gough, SC ;
Savage, CO ;
Franklyn, JA .
CLINICAL ENDOCRINOLOGY, 2004, 60 (06) :671-675
[10]  
Hattori M, 2001, J AM SOC NEPHROL, V12, P1493, DOI 10.1681/ASN.V1271493